Professional
Added to YB: 2024-09-27
Pitch date: 2024-09-26
BNN.DE [neutral]
BRAIN Biotech AG
+17.94%
current return
Author Info
ToffCap are full-time fund managers finding undervalued opportunities and a reason why the price should (start to) move in the right direction. Sign up for their newsletter.
Company Info
BRAIN Biotech AG engages in the research and development of Bio-based products and solutions in Germany, the United States, France, the Netherlands, and the United Kingdom.
Market Cap
EUR 51.6M
Pitch Price
EUR 2.23
Price Target
N/A
Dividend
N/A
Sector
Chemicals
Category
turnaround
BRAIN Biotech: Undervalued Gem? €129M Deal Highlights Pipeline Potential
BNN.DE (potential turnaround): €129M royalty deal (€18.4M upfront, €18.4M on approvals, €92M on sales milestones) vs €48M market cap. Deal showcases pipeline potential. Co. plans to monetize more high-value projects. Stock underperformed as platforms missed expectations, but deal signals turnaround potential.
Read full article (1 min)